nference to Present AI-Driven Research at 2024 ASCO Annual Meeting
nference , a company dedicated to transforming healthcare by making biomedical data computable, will present research at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4 in Chicago.
- nference , a company dedicated to transforming healthcare by making biomedical data computable, will present research at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4 in Chicago.
- "This recent study demonstrates how AI and real-world data can drive innovation in oncology, enabling more precise and efficient cancer care and research."
- Results showed 99.8% sensitivity and 98.2% accuracy at the sentence level, and 92.5% sensitivity and 88.0% accuracy at the patient level.
- A second abstract was accepted by ASCO for online publication, titled Clinical nSights: A software platform to accelerate real world oncology analyses .